Jia-Lin Ma Nianhan, Stern David F
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Cell Cycle. 2008 Mar 15;7(6):808-17. doi: 10.4161/cc.7.6.5595. Epub 2008 Jan 8.
Rad53, the ortholog of mammalian Chk2, is a major DNA damage checkpoint effector kinase in Saccharomyces cerevisiae. Despite extensive studies on the genetic requirements for Rad53 activation and its linkage downstream to checkpoint responses, the mechanism of Rad53 activation is not completely understood. Rad53-dependent signal amplification is thought to be a primary force that accelerates checkpoint signal transduction processes in response to DNA damage. Rad53 forms oligomers upon DNA damage in vivo. It is not clear how oligomer formation affects Rad53 activation and what is the mechanism of Rad53 oligomerization. Here, we monitor Rad53 oligomer assembly and disassembly in vitro. These processes are ATP-dependent and are regulated through phosphorylation. Mutations in FHA or SCD domains of RAD53 compromise intermolecular autophosphorylation activity and these domains are indispensable for Rad53 oligomerization. The mediator Rad9 is not necessary for Rad53 oligomerization. Rad53 kinase activity is required for disassembly of Rad53 oligomers in vivo after DNA damage. Moreover, induced oligomerization of Rad53 efficiently activates Rad53 in the absence of Mec1 in vivo. The results support the conclusions that Rad53/Chk2 homo-oligomerization is an evolutionarily conserved mechanism that drives Rad53/Chk2 activation and promotes signal amplification in DNA damage responses.
Rad53是哺乳动物Chk2的直系同源物,是酿酒酵母中一种主要的DNA损伤检查点效应激酶。尽管对Rad53激活的遗传需求及其下游与检查点反应的联系进行了广泛研究,但Rad53激活的机制仍未完全了解。Rad53依赖的信号放大被认为是加速DNA损伤反应中检查点信号转导过程的主要力量。Rad53在体内DNA损伤时形成寡聚体。目前尚不清楚寡聚体的形成如何影响Rad53的激活以及Rad53寡聚化的机制是什么。在这里,我们在体外监测Rad53寡聚体的组装和解聚。这些过程依赖于ATP,并通过磷酸化进行调节。RAD53的FHA或SCD结构域中的突变会损害分子间自磷酸化活性,并且这些结构域对于Rad53寡聚化是必不可少的。介导因子Rad9对于Rad53寡聚化不是必需的。DNA损伤后,体内Rad53寡聚体的解聚需要Rad53激酶活性。此外,在体内缺乏Mec1的情况下,诱导的Rad53寡聚化能有效激活Rad53。这些结果支持以下结论:Rad53/Chk2同源寡聚化是一种进化上保守的机制,可驱动Rad53/Chk2激活并促进DNA损伤反应中的信号放大。